These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2651533)

  • 21. Pathogenesis of Shigella diarrhea. VIII. Evidence for a translocation step in the cytotoxic action of Shiga toxin.
    Jacewicz M; Keusch GT
    J Infect Dis; 1983 Nov; 148(5):844-54. PubMed ID: 6355319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of Shiga toxin and other cytotoxins with the neurologic manifestations of shigellosis.
    Ashkenazi S; Cleary KR; Pickering LK; Murray BE; Cleary TG
    J Infect Dis; 1990 May; 161(5):961-5. PubMed ID: 2324546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis of shigella diarrhea: evidence for a developmentally regulated glycolipid receptor for shigella toxin involved in the fluid secretory response of rabbit small intestine.
    Mobassaleh M; Donohue-Rolfe A; Jacewicz M; Grand RJ; Keusch GT
    J Infect Dis; 1988 May; 157(5):1023-31. PubMed ID: 3283253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Release of Shiga toxin from Shigella dysenteriae 1 by polymyxin B.
    Griffin DE; Gemski P
    Infect Immun; 1983 Apr; 40(1):425-8. PubMed ID: 6299964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Environmental and human isolates of Vibrio cholerae and Vibrio parahaemolyticus produce a Shigella dysenteriae 1 (Shiga)-like cytotoxin.
    O'Brien AD; Chen ME; Holmes RK; Kaper J; Levine MM
    Lancet; 1984 Jan; 1(8368):77-8. PubMed ID: 6140426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of Shiga toxin and other cytotoxins by serogroups of Shigella.
    Bartlett AV; Prado D; Cleary TG; Pickering LK
    J Infect Dis; 1986 Dec; 154(6):996-1002. PubMed ID: 3537154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shigella toxin and the pathogenesis of shigellosis.
    Keusch GT; Donohue-Rolfe A; Jacewicz M
    Ciba Found Symp; 1985; 112():193-214. PubMed ID: 3847336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli.
    O'Brien AD; LaVeck GD; Thompson MR; Formal SB
    J Infect Dis; 1982 Dec; 146(6):763-9. PubMed ID: 6754826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Entry of Shigella dysenteriae toxin into HeLa cells.
    Eiklid K; Olsnes S
    Infect Immun; 1983 Nov; 42(2):771-7. PubMed ID: 6358031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shiga toxin--an expanding role in the pathogenesis of infectious diseases.
    Cantey JR
    J Infect Dis; 1985 May; 151(5):766-71. PubMed ID: 3886803
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunochemical and cytotoxic activities of Shigella dysenteriae 1 (shiga) and shiga-like toxins.
    O'Brien AD; Laveck GD
    Infect Immun; 1982 Mar; 35(3):1151-4. PubMed ID: 7040247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxicity of Shigella dysenteriae 1 for cultured mammalian cells.
    Hale TL; Formal SB
    Am J Clin Nutr; 1980 Nov; 33(11 Suppl):2485-90. PubMed ID: 7001884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and characterization of functional Shiga toxin subunits and renatured holotoxin.
    Donohue-Rolfe A; Jacewicz M; Keusch GT
    Mol Microbiol; 1989 Sep; 3(9):1231-6. PubMed ID: 2677606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deletion of the Shiga toxin gene in a chlorate-resistant derivative of Shigella dysenteriae type 1 that retains virulence.
    Neill RJ; Gemski P; Formal SB; Newland JW
    J Infect Dis; 1988 Oct; 158(4):737-41. PubMed ID: 3049838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relation between production of cytotoxin and clinical features in shigellosis.
    Prado D; Cleary TG; Pickering LK; Ericsson CD; Bartlett AV; DuPont HL; Johnson PC
    J Infect Dis; 1986 Jul; 154(1):149-55. PubMed ID: 3519788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A monoclonal antibody to Shigella dysenteriae serotype 13 cross-reacting with Shiga toxin.
    Qadri F; Azim T; Hossain A; Islam D; Mondol G; Faruque SM; Albert MJ
    FEMS Microbiol Lett; 1993 Mar; 107(2-3):343-7. PubMed ID: 8472916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification of a lethal toxin produced by Shigella dysenteriae.
    Okamoto K; Takeda Y; Miwatani T
    Toxicon; 1982; 20(2):451-6. PubMed ID: 7043787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial heterogeneity in Shiga toxin receptors and responses.
    Obrig TG; Louise CB; Lingwood CA; Boyd B; Barley-Maloney L; Daniel TO
    J Biol Chem; 1993 Jul; 268(21):15484-8. PubMed ID: 8340376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocytosis and intracellular transport of the glycolipid-binding ligand Shiga toxin in polarized MDCK cells.
    Sandvig K; Prydz K; Ryd M; van Deurs B
    J Cell Biol; 1991 May; 113(3):553-62. PubMed ID: 1901867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography.
    O'Brien AD; LaVeck GD; Griffin DE; Thompson MR
    Infect Immun; 1980 Oct; 30(1):170-9. PubMed ID: 7002787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.